Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-Andes orthohantavirus Neutralizing Antibodies in Patient Samples
Andes orthohantavirus (ANDV) is the etiologic agent of hantavirus cardiopulmonary syndrome (HCPS), which has a case fatality rate around 35%, with no effective treatment or vaccine available. ANDV neutralizing antibody (NAb) measurements are important for the evaluation of the immune response follow...
Main Authors: | Cecilia Vial, Annalis Whitaker, Jan Wilhelm, Jimena Ovalle, Ruth Perez, Francisca Valdivieso, Marcela Ferres, Constanza Martinez-Valdebenito, Philip Eisenhauer, Gregory J. Mertz, Jay W. Hooper, Jason W. Botten, Pablo A. Vial |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcimb.2020.00444/full |
Similar Items
-
Deletions in Genes Participating in Innate Immune Response Modify the Clinical Course of Andes Orthohantavirus Infection
by: Grazielle Esteves Ribeiro, et al.
Published: (2019-07-01) -
Rodent-Borne Orthohantaviruses in Vietnam, Madagascar and Japan
by: Fuka Kikuchi, et al.
Published: (2021-07-01) -
Bivalent VSV Vectors Mediate Rapid and Potent Protection from Andes Virus Challenge in Hamsters
by: Joshua Marceau, et al.
Published: (2024-02-01) -
Phylogenetic Characterization of Orthohantavirus dobravaense (Dobrava Virus)
by: Mert Erdin, et al.
Published: (2024-04-01) -
Case of Human Orthohantavirus Infection, Michigan, USA, 2021
by: Samuel M. Goodfellow, et al.
Published: (2024-04-01)